BlepharoptosisNCT02367677
Digital Photographs to Evaluate Blepharoptosis
An observational study of Blepharoptosis, run by CHU de Quebec-Universite Laval at 1 site in Canada.
Trial summary
To compare measurements made by a computer software (ImageJ) made on photographs to the traditional clinical measures with a ruler in the evaluation of blepharoptosis Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Blepharoptosis
- What is being tested?
- Method comparison
- How many people
- 36 participants
- Where
- 1 siteCanada
- Study dates
- Nov 2013to 30 Nov 2016
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Patients with ptosis of all causes
Who may be able to join
- Patients 18 years old or older
- Patients presenting for evaluation of blepharoptosis of any kind except the one mentioned in the exclusion criteria
Who cannot join
- Myasthenia gravis
- Thyroid eye disease
Trial locations and contacts
1 site in 1 country.
Canada1 site
Centre Universitaire d'Ophtalmologie, Hôpital du Saint-Sacrement, CHU de Québec
Québec, Quebec, G1S 4L8
About this study
Official title: Comparison Between Clinical Measurements and Computer-based Measurements on Digital Photographs to Evaluate Blepharoptosis
To compare measurements made by a computer software (ImageJ) made on photographs to the traditional clinical measures with a ruler in the evaluation of blepharoptosis
- Conditions
- Blepharoptosis
- Being tested
- Method comparison
- Keywords
- Photo
- Medical subject headings
- Blepharoptosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Method comparisonOther
| Study group | Role | What they receive |
|---|---|---|
| Clinical measurements | Measurements are made with a paper ruler Receives: Other: Method comparison | |
| Smartphone | Measurements are made with ImageJ from pictures taken with an iPhone 6 Receives: Other: Method comparison | |
| Digital camera | Measurements are made with ImageJ from pictures taken with a Nikon D700 Receives: Other: Method comparison |
What is being measured
The primary outcome is the main question the study is designed to answer.
Reliability of measurements made on photographs to evaluate blepharoptosis
Comparison between measurements made on digital photographs with measurements made with a ruler in clinic
Measured: Same day
Reliability of measurements made on photographs taken by smartphone to evaluate blepharoptosis
Comparison between measurements made on digital photographs taken by smartphone with measurements made on digital photographs taken with a digital camera
Measured: Same day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Feb 2015 (estimated)
- Study startNov 2013
- Primary completion30 Nov 2016
- Study completion30 Nov 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for BlepharoptosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 36 participants (actual)
Sponsor and investigators
- Lead sponsor
- CHU de Quebec-Universite Laval
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Yvonne Molgat, MDCM, FRCSC, Principal investigator, Centre de recherche du CHU de Québec : Université Laval
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02367677
- Sponsor's protocol ID
- 2015-1905, C14-06-1905
- Status last verified
- Aug 2016
- First submitted
- 3 Feb 2015
- Last updated
- 2 Feb 2017
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 2 Feb 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison Between Clinical Measurements and Computer-based Measurements on Digital Photographs to Evaluate Blepharoptosis
- ClinicalTrials.gov ID
- NCT02367677
- Acronym / sponsor ID
- 2015-1905, C14-06-1905
- Conditions
- Blepharoptosis
- Keywords
- Photo
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 36 participants (actual)
- Lead sponsor
- CHU de Quebec-Universite LavalUniversity, hospital or other
- Study start
- Nov 2013
- Primary completion
- 30 Nov 2016 (actual)
- Study completion
- 30 Nov 2016 (actual)
- First posted
- 20 Feb 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To compare measurements made by a computer software (ImageJ) made on photographs to the traditional clinical measures with a ruler in the evaluation of blepharoptosis
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Clinical measurements | – | Other: Method comparisonMeasurements are made with a paper ruler |
| Smartphone | – | Other: Method comparisonMeasurements are made with ImageJ from pictures taken with an iPhone 6 |
| Digital camera | – | Other: Method comparisonMeasurements are made with ImageJ from pictures taken with a Nikon D700 |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with ptosis of all causes
Key inclusion criteria (2 listed)
- Patients 18 years old or older
- Patients presenting for evaluation of blepharoptosis of any kind except the one mentioned in the exclusion criteria
Key exclusion criteria (2 listed)
- Myasthenia gravis
- Thyroid eye disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Method comparison | Other | Clinical measurements, Digital camera, Smartphone |
Primary outcome
Reliability of measurements made on photographs to evaluate blepharoptosis
Time frame: Same day
Comparison between measurements made on digital photographs with measurements made with a ruler in clinic
Reliability of measurements made on photographs taken by smartphone to evaluate blepharoptosis
Time frame: Same day
Comparison between measurements made on digital photographs taken by smartphone with measurements made on digital photographs taken with a digital camera
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Feb 2017.
- Individual participant dataSharing planned: Undecided
Related trials for Blepharoptosis
RecruitingObservational study
Blepharoptosis After Repeated Intravitreal Anti-VEGF Injections: A Prospective Study
Blepharoptosis, Age-Related Macular Degeneration
Not yet recruitingPhase 4
The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients
Glaucoma, Glaucoma, Open-Angle
Not yet recruiting
Effect of Suture Material on Eyelid Height Stability After Anterior White-Line Advancement for Aponeurotic Ptosis.
Blepharoptosis
Active, not recruitingObservational study
Performance and Safety Assessment of SPRING THREAD® Elastic Tensor Thread in Patients With Mild to Moderate Facial Ptosis.
Ptosis, Ptosis, Mild
Recruiting
A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis
Blepharoptosis, Device Usability
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yvonne Molgat, MDCM, FRCSC principal investigator
Centre de recherche du CHU de Québec : Université Laval
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Blepharoptosis, run by CHU de Quebec-Universite Laval at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reliability of measurements made on photographs to evaluate blepharoptosis (time frame: Same day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2017; AzTrials last refreshed its copy on 31 Oct 2026.